Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Journal of Immunotherapy and Precision Oncology|May 22, 2023
Targeting Cancer Metabolism to Improve Outcomes with Immune Checkpoint InhibitorsZainab Fatima, Abdulrahman Abonofal, Bettzy StephenPancreas|February 10, 2021
Hypercalcemia of Malignancy and Acute PancreatitisZaid Imam, Angy Hanna, Diana Jomaa, et al.Cancers|August 12, 2023
A Phase II Clinical Trial of Pembrolizumab Efficacy and Safety in Advanced Renal Medullary CarcinomaChijioke Nze, Pavlos Msaouel, Mohamed H Derbala, et al.Gynecologic Oncology|June 15, 2020
Phase II study of pembrolizumab efficacy and safety in women with recurrent small cell neuroendocrine carcinoma of the lower genital tractMichael Frumovitz, Shannon N Westin, Gloria Salvo, et al.Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|November 19, 2023
NSAIDs do not reduce severity among post-ERCP pancreatitis patientsBara El Kurdi, Zaid Imam, Abdulrahman Abonofal, et al.Investigational New Drugs|January 8, 2021
The clinical efficacy and safety of single-agent pembrolizumab in patients with recurrent granulosa cell tumors of the ovary: a case series from a phase II basket trialJeffrey A How, Amir Jazaeri, Shannon N Westin, et al.Journal for Immunotherapy of Cancer|May 26, 2022
Efficacy of pembrolizumab in patients with advanced cancer of unknown primary (CUP): a phase 2 non-randomized clinical trialKanwal P Raghav, Bettzy Stephen, Daniel D Karp, et al.Pageof 1